Rob Rinderman News Today

CanaQuest Medical Corp.: CanaQuest Files International Mentanine Patent, a Scientific CBD Formulation for Mental Health ") , an award-winning Life Science/Pharmaceutical company developing formulations combining cannabinoid molecules with pharmaceutical-grade botanical compounds, today announced the filing of its International Patent, trade named Mentanine®, which has demonstrated at least 10-times (10X) the efficacy compared to Pharma Grade CBD. Mentanine® - an International CBD Excellenc...

(0) TORONTO, ON / ACCESSWIRE / April 7, 2021 / CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the "Company" or "CanaQuest") , an award-winning Life Science/Pharmaceutical company developing health and wellness products combining cannabinoid molecules with pharmaceutical-grade botanical compounds, today announced that Rob Rinderman has joined CanaQuest as its new Director of Communications. Mr. Rinderman will focus on managing a proactive investor relations and corporate communications program, furthe...